News Quantified

ARCT – arcturus therapeutics holdings inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

CSL initiated with an Overweight at Morgan Stanley [Yahoo! Finance]

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $74.00 to $68.00. They now have a "buy" rating on the stock.

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) was given a new $48.00 price target on by analysts at BTIG Research.

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its price target lowered by analysts at HC Wainwright from $63.00 to $60.00. They now have a "buy" rating on the stock.

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

-8.9%

MISS

-8.9%

MISS

-8.9%

MISS

-8.9%

MISS

Canaccord Genuity

Cantor Fitzgerald

Cantor Fitzgerald

Form 10-K Arcturus Therapeutics For: Dec 31

Form 8-K Arcturus Therapeutics For: Mar 06

Form SCHEDULE 13G Arcturus Therapeutics Filed by: STATE STREET CORP

Top News Gainers

4/27 Arcturus Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate 29.7%

3/15 Arcturus Therapeutics Holdings Inc. Analysts Are Pretty Bullish On The Stock After Recent Results [Yahoo! Finance News] 22.1%

3/23 Form SEC STAFF LETTER Arcturus Therapeutics 19.3%

3/4 Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR Technology™ 15.7%

8/15 Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] 14.3%

3/5 Arcturus Therapeutics Ltd (NASDAQ: ARCT) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. 14.1%

7/30 Form EFFECT Arcturus Therapeutics 12.5%

6/20 Form 8-K Arcturus Therapeutics For: Jun 18 Filed by: Arcturus Therapeutics Holdings Inc. 12.3%

9/23 Arcturus Therapeutics Announces Appointment of Dr. Edward Holmes M.D. and Re-Appointment of Andy Sassine to the Board of Directors 11.9%

6/20 Arcturus Therapeutics Ltd (NASDAQ: ARCT) was given a new $18.00 price target on by analysts at Chardan Capital. They now have a "buy" rating on the stock. 11.3%

Top News Decliners

3/12 Arcturus Therapeutics Holdings, Inc. (ARCT) CEO Joseph Payne on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -29.3%

4/28 Thinking about trading stocks or options in Arcturus Therapeutics, Laboratory Corp. of America, Bed Bath & Beyond, Moderna, or Zillow? -13.4%

3/27 Form 8-K Arcturus Therapeutics For: Mar 27 -13.2%

5/10 Q1/2019 3/31/2019 EPS -0.680 ZacksConsensus N/A ActVsEst N/A - N/A -13.2%

8/5 Form 424B5 Arcturus Therapeutics -12.9%

8/1 Form 8-K Arcturus Therapeutics For: Aug 01 -12.1%

8/15 Q2/2019 6/30/2019 EPS -0.070 ZacksConsensus -0.530 ActVsEst 0.460 - Beat -11.9%

9/26 Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock -9.8%

3/19 Arcturus Therapeutics Ltd (NASDAQ: ARCT) had its "buy" rating re-affirmed by analysts at Robert W. Baird. They now have a $26.00 price target on the stock. -8.4%

2/24 Arcturus Therapeutics to Report Fourth Quarter and Year-End 2019 Financial Results and Provide Corporate Update on March 11 -8.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day